The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Market Growth Overview:

• The dry powder inhaler market has experienced strong growth in recent years.
• Expected to grow from $20.18 billion in 2023 to $21.25 billion in 2024 at a CAGR of 5.3%.
• Forecasted to reach $25.82 billion in 2028 at a CAGR of 5.0%.

Factors Driving Growth:

• Rising prevalence of respiratory diseases.
• Technological advancements in manufacturing processes.
• Government incentives and policies supporting healthcare.
• Global economic factors influencing market dynamics.

Rising Prevalence Of Respiratory Diseases Fuels Growth

Prevalence of Respiratory Diseases:

• Respiratory diseases encompass a broad category of medical conditions affecting the respiratory system.
• Conditions include asthma, COPD, cystic fibrosis, among others.

Impact on Market:

• Dry powder inhalers deliver medicine directly to the lungs, providing effective treatment.
• Rise in respiratory disease-related deaths drives market growth.

Read More On The Dry Powder Inhaler Market Report 2024 – https://www.thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report

Major Players in the Market

Key Companies:

• Novartis AG
• AstraZeneca plc.
• GlaxoSmithKline PLC
• Boehringer Ingelheim GmbH
• Catalent Inc.
• And many more…

Innovations in Dry Powder Inhalers:

• Development of muscarinic antagonist drugs for COPD treatment.
• Launch of long-acting muscarinic antagonist dry powder inhalers.
• Acquisitions to enhance DPI manufacturing capabilities.

Catalent Inc. Enhances DPI Manufacturing Capabilities

Strategic Acquisition:

• Catalent Inc. acquires Acorda Therapeutics Inc. to expand DPI manufacturing capabilities.
• Adds commercial-stage products to portfolio for respiratory and neurological diseases.

Market Segmentation and Regional Analysis

Market Segments:

1. Product: Single-Dose Inhalers, Multi-Dose Inhalers
2. Function: Manually Operated, Digitally Operated
3. Application: Asthma, COPD, Cystic Fibrosis, Other Applications
4. End User: Hospitals, Homecare Settings, Ambulatory Surgical Centers

Regional Insights:

• North America leads the market, with significant growth potential in other regions.

Conclusion

The dry powder inhaler market is witnessing steady growth, driven by the rising prevalence of respiratory diseases and advancements in treatment options. Major players are focusing on innovation and strategic acquisitions to expand their product portfolios and manufacturing capabilities. With continued emphasis on healthcare and technological advancements, the market is poised for further expansion in the coming years, revolutionizing respiratory healthcare worldwide

Request for A Sample Of The Global Dry Powder Inhaler Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=13430&type=smp